Type 2 Diabetes is a major public health challenge in MENA. The International Diabetes Federation estimates that, in 2010, 37 million people in the MENA region have diabetes which is equivalent to 9.3% of the world’s adults with diabetes. By 2035, this is expected to rise to 68 million. Six of the region’s countries appear in the list of the 10 countries with the highest average prevalence of diabetes in the world.

Reversing this trend will require a call to action through public education on national levels. Tabuk has formed a strong partnership with organizations and institutions which have the common goal to combat Diabetes by giving our time, talent and resources. Extensive educational activities, around the importance of a healthy lifestyle, targeting the student population have been conducted as this is when habits are formed. Screening projects have been supported as earlier detection can delay the onset of complications. We recognize that building awareness diabetes is essential but we don’t stop there. We also aim to improve and facilitate the exchange of knowledge and expertise across the region through scientific exchange meetings across the region.


In June 2011, a Royal decree (A/121) was announced entitling Saudi women to work in pharmaceutical factories. Up to 2012, female employees did not exist at Tabuk Pharmaceuticals in Saudi Arabia.

In 2014 Tabuk Pharmaceuticals initiated a project to support gender diversity and inclusion. Women were recruited and enrolled in extensive training & development programs, to enhance technical capabilities and leadership skills. Today women in Tabuk Pharmaceuticals work in a variety of areas such as, quality assurance, manufacturing, quality control, administration, finance and human resources. Opportunities for career development and growth are continually provided. Female staff now constitutes 10% of the work force at Tabuk Pharmaceuticals, KSA.